Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravenous vs. Intracoronary Use of Abciximab.

Trial Profile

Intravenous vs. Intracoronary Use of Abciximab.

Phase of Trial: Phase III

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Abciximab (Primary) ; Abciximab (Primary)
  • Indications Coronary stent thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in Cardiology.
    • 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top